Decoding the gene networks that drive healthy human development and understanding how their disruption leads to conditions such as congenital heart disorders and childhood cancers using innovative bioinformatics approaches.

The Transcriptomics & Bioinformatics group is a multidisciplinary team of computational and molecular biologists who specialise in mining genomic information to uncover the genetic causes of childhood diseases such as congenital heart disease (CHD) and cancer.

The group focuses on understanding the role of the non-coding genome in development and disease by developing novel software, data-mining pipelines, and conducting bioinformatics research in collaboration with laboratories at MCRI and beyond.

Challenges facing children and adolescents

The formation of healthy babies relies on a network of genes activated at precise times and locations during embryonic development. Disruption of this network can lead to congenital malformations.

Therefore, it is essential to:

  • Identify the genetic components of this regulatory network
  • Understand where and when these genes are activated to better understand healthy development and the origins of genetic malformations.

Our current research

The team applies systems biology approaches to reconstruct developmental gene regulatory networks required for healthy development and to understand how alterations lead to congenital malformations.

The group develops new software for -omics data mining (genomics, epigenomics, single-cell and spatial transcriptomics, networks) and 3D data visualisation platforms, making complex data intuitive for researchers, clinicians, and broader audiences.

The group collaborates with life scientists and clinicians worldwide to harness bioinformatics for breakthrough discoveries in embryonic development and congenital disease, driving the next generation of translational medicine.

Future impact on children and adolescents

Our bioinformatics research provides essential resources to collaborating laboratories, enabling deeper insights into genes and their roles in health and disease.

Our data-mining work also supports the development of gene panels with proven predictive power, which are vital for reliable diagnostic tests for parents and babies.

reNEW Bioinformatics Hub

The Transcriptomics and Bioinformatics group hosts the reNEW Bioinformatics Hub, co-directed by Prof Mirana Ramialison and A/Prof Fernando Rossello, as part of the global Novo Nordisk Foundation Center for Stem Cell Medicine (reNEW). Through this collaboration, our bioinformaticians provide integrated analytical support across three nodes:

Contact us

Mirana Ramialison, Group Leader
Phone: show phone number
Email: